Carrier Testing Services Market is expected to reach US$2,310.79 Million by 2031

Expanded Carrier Screening Segment Leads Carrier Testing Services Market Growth Based on Type

According to our new research study on “Carrier Testing Services Market Forecast to 2031 – Global Analysis – by Type, Medical Condition, and End User,” the market is expected to grow from US$791.19 million in 2024 to US$2,310.79 million by 2031, registering a CAGR of 16.9% during 2025–2031. Major factors driving the carrier testing services market expansion include the rising prevalence of genetic diseases, increasing personalized/preventive healthcare focus, and favorable government & regulatory support.

The​‍​‌‍​‍‌​‍​‌‍​‍‌ carrier testing services market growth is driven by the advancement of genomic technologies and the awareness of inherited disorders. The shift to preventive and personalized healthcare is prompting more individuals and healthcare providers to incorporate carrier screening into preconception and prenatal care. Carrier screening panels and at-home genetic test kits are enabling thorough testing and increasing access to it for more people. A supportive regulatory environment and continuous innovation in sequencing technologies are making the tests accurate, affordable, and convenient. The market is moving toward a more comprehensive, proactive genetic risk assessment to facilitate informed reproductive decision-making and improve health outcomes.

Carrier Testing Services Market, by Region, 2024 (%)

Source: The Insight Partners Analysis

Carrier Testing Services Market Analysis Based on Segmental Evaluation:

By type, the market is segmented into expanded carrier screening, targeted disease carrier screening. Expanded carrier screening accounted for the largest carrier testing services market share in 2024. Expanded carrier screening (ECS) is experiencing significant market growth, driven by new clinical guidelines, innovative product launches, and the increasing adoption of large-scale screening programs worldwide. The ECS panels enable the simultaneous testing of hundreds of genes linked to severe recessive and X-linked conditions, making reproductive risk assessment more comprehensive and inclusive.

The scope of the carrier testing services market report encompasses an assessment of the market's performance in North America, Europe, Asia Pacific, South America, Central America, the Middle East, and Africa. In terms of revenue, North America dominated the carrier testing services market in 2024.

The carrier testing services market in North America is segmented into the US, Canada, and Mexico. North America accounted for nearly half of the total global share in 2024. The carrier testing services market in North America is segmented into the US, Canada, and Mexico. Carrier testing services in North America remain a well-established practice and a global trendsetter. The penetration of carrier screening into reproductive care is a result of the region’s advanced healthcare infrastructure, high awareness of genetic disorders, and extensive use of next-generation sequencing. In the US, carrier testing is a standard part of preconception and prenatal procedures, with the assistance of genetic counselors who form a solid network and support couples in understanding their risks. The insurance system and healthcare policy of the region are pretty supportive of gene screening, facilitating testing by individuals. These factors maintain a high demand level among fertility clinics, obstetrics practices, and diagnostic labs, as well as allow North America to be a trendsetter in preventive reproductive genomics.

The US boasts a well-developed healthcare system where the use of genetic counseling, next-generation sequencing (NGS), and carrier screening panels is the norm. Leading laboratories and companies, such as Natera, maintain CLIA-certified facilities, which enable them to provide thorough carrier tests. Expanded carrier screening is widely accepted in reproductive medicine as well as in preconception and prenatal care. Ethical and regulatory measures, such as the Genetic Information Nondiscrimination Act (GINA), are implemented to alleviate people's concerns regarding the use of their genetic data. There is a deepening connection between carrier testing and assisted reproduction – couples going through IVF or those wishing to build a family choose to do carrier tests to figure out the chance of inheritable diseases. The US carrier testing market is very competitive and technology-driven, and is making progress toward preventive and personalized reproductive health through carrier screening.

Eurofins Scientific SE, Quest Diagnostics Inc, Myriad Genetics Inc, Illumina Inc, Thermo Fisher Scientific Inc., OPKO Health Inc, Laboratory Corp of America Holdings, Fulgent Genetics, Inc, MedGenome Inc, and Gene By Gene Ltd are among the leading companies profiled in the carrier testing services market report.

Based on type, the carrier testing services market is segmented into expanded carrier screening, targeted disease carrier screening. In terms of medical condition, the carrier testing services market is segmented into pulmonary conditions, hematological conditions, neurological conditions, and other medical conditions. The pulmonary conditions segment held the largest carrier testing services market share in 2024. Based on end user, the carrier testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and other end users. Based on geography, the market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com